What are the analyst price targets for MBOT after FDA approval?

There are no available analyst price targets for MBOT after FDA approval. The most recent data indicates that the average target price for MBOT is $9.00, based on a single analyst rating. However, this target price is from a date before the expected FDA approval, and it is unclear if analysts have updated their targets following the recent developments.